China is a region with a high incidence of gastric diseases, and the incidence of gastric cancer is the highest in the world. Early symptoms of gastric cancer are similar to those of gastritis, so regular gastroscopy plays a crucial role in early detection, treatment, and improving the cure rate of gastric cancer, but the discomfort of traditional gastroscopy and the risk of infection have made many people give up traditional gastroscopy health screening.
Ann Han's Navicam capsule endoscopy robotic system brings a brand new experience to gastric examination: just swallow a capsule endoscope with water, and the painless, non-invasive, non-infectious, and dead-end gastric examination can be completed in about 15 minutes. At the same time, it also has several major characteristics of quick examination, clear image and quick operation (for doctors). The accuracy rate is up to 93.4%.
After years of research and development, Anhan's NaviCamTM capsule endoscopy robotics technology spans a wide range of fields, including sensing, optoelectronic imaging, image processing, wireless communications, device packaging, etc., with more than 300 original parts hidden in the "stomach", including more than 40 international technology patents.
Ann Han's Navicam capsule endoscopy robotic system has been used in hundreds of hospitals, including Peking Union Medical College Hospital, General Hospital of the People's Liberation Army (301 Hospital), and other hospitals, since it was granted a medical device registration certificate in January 2013 by the State Food and Drug Administration (CFDA). At the same time, the Navicam capsule endoscopy robotic system has been used in large-scale medical checkup centers such as Meinian Dahua Health and Aikang Guobin soon after its launch, and has been favored by people who are concerned about their personal health.